Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Xi-Nan Cen"'
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-7 (2021)
Abstract Background Multiple myeloma (MM) is a plasma-cell derived hematologic malignant disease. The malignant proliferating plasma cells secrete massive monoclonal immunoglobulins which lead to various pathologic types of renal injury. Myeloma cast
Externí odkaz:
https://doaj.org/article/1801b4e9a8ec4b6e8397552b0e01dc4c
Autor:
Bing-Jie Wang, Zhi-Hao Liu, Qing-Yun Wang, Wei Liu, Bo Tang, Zhi-Xiang Qiu, Wen-Sheng Wang, Mang-Ju Wang, Jin-Ping Ou, Han-Yun Ren, Xi-Nan Cen, Peng Lyu
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 10, Pp 1230-1232 (2021)
Externí odkaz:
https://doaj.org/article/3dd660b4855744c48f23269ed15e57ae
Autor:
Jing Shen, Jianmin Luo, Hang Su, Xi-Nan Cen, Aichun Liu, Quan-Shun Wang, Liping Su, Huilai Zhang, Jianxia He, Wei Zhang, Shuye Wang, Yuhuan Song, Daobin Zhou, Yuhuan Gao, Zengjun Li, Jing-Wen Wang, Hongmei Jing, Owen A. O'Connor, Hui Liu, Lihong Liu
Publikováno v:
Cancer Biology & Medicine, Vol 18, Iss 3, Pp 841-848 (2021)
Cancer Biology & Medicine
Cancer Biology & Medicine
Objective: To assess the efficacy and safety of the novel histone deacetylase inhibitor, chidamide, in combination with cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone (Chi-CHOEP) for untreated peripheral T-cell lymphoma (PTCL).
Autor:
Junhui Xu, Zhengyang Song, Lin Nong, Miao Yan, Bingjie Wang, Huihui Liu, Kunyan Sun, Mang-Ju Wang, Liang Gao, Xi-Nan Cen
Publikováno v:
OncoTargets and therapy
Background Myelomatous pleural effusion (MPE), as a presentation of extramedullary infiltration of multiple myeloma (MM), is rare and currently associated with poor outcomes without effective therapy. The potential value of cytokine detection in pleu
Publikováno v:
Cancer Management and Research
Junhui Xu,* Mangju Wang,* Ye Shen, Miao Yan, Weiwei Xie, Bingjie Wang, Huihui Liu, Xinan Cen Department of Hematology, Peking University First Hospital, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondenc
Autor:
Ting Niu, Steven Sun, Ming Qi, Yafei Wang, Weijun Fu, Jin Lu, Gang An, Xi-Nan Cen, Lijuan Chen, Maria-Victoria Mateos, Ajay K. Nooka, Jianda Hu, Jie Jin, Weiping Liu, Andrew Spencer, Xiao-Jun Huang, Wei Li, Xue Gai, Chengcheng Fu, Zhen Cai, Xue Yang, Katja Weisel, Zheng Ge
Publikováno v:
Blood. 136:38-41
Introduction: Daratumumab is a human IgGκ monoclonal antibody targeting CD38 with a direct on-tumor and immunomodulatory mechanism of action. In phase 3 clinical studies, the addition of daratumumab to standard-of-care regimens consistently demonstr
Autor:
YONG-QIU WEI1, XI-NAN CEN1 90701137@bjmu.edu.cn, HUI-HUI LIU1, YU-HUA SUN1, YONG-JIN SHI1, WEI LIU1, YU-JUN DONG1, HAN-YUN REN1
Publikováno v:
Oncology Letters. Jun2017, Vol. 13 Issue 6, p4101-4108. 8p.
Autor:
Miao Yan, Xi-Nan Cen, Jin-Ping Ou, Wen-Sheng Wang, Li-Hong Wang, Ping Zhu, Hanyun Ren, Yu-Hua Sun, Lin Nong, Bingjie Wang, Mang-Ju Wang
Publikováno v:
Diagnostic Cytopathology
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy arising from plasmacytoid dendritic cell precursors. The disease typically manifests in the skin, but it also evolves into a leukemic phase or can be
Autor:
Mang-Ju Wang, Yu-Jun Dong, Huihui Liu, Junhui Xu, Xi-Nan Cen, Zhi-Xiang Qiu, Wei-Lin Xu, Jin-Ping Ou, Ping Zhu, Wen-Sheng Wang, Hanyun Ren, Fuchu He, Qian Wang, Miao Yan
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 8, Pp 2803-2811 (2020)
Cancer Medicine, Vol 9, Iss 8, Pp 2803-2811 (2020)
Background Universal gene targets are in persistent demand by real‐time quantitative polymerase chain reaction (RT‐qPCR)‐based methods in acute leukemia (AL) diagnosis and monitoring. Human Krüppel‐like factor 3 (hKLF3), a newly cloned human
Autor:
Rongfu Wang, Guangyu Zhao, Xuchu Zhang, Xueqi Chen, Xiang Li, Xi-nan Cen, Zhanli Fu, Yan Fan, Meng Liu, Jing Ning, Jianhua Zhang, Jing Zhao
Publikováno v:
Nuclear medicine communications. 43(2)
Objective T cell lymphomas are associated with an aggressive worse prognosis. This study is designed to assess T cell lymphomas using 18F-FDG PET/CT. Methods Sixty-four patients with newly diagnosed T cell lymphomas underwent PET/computed tomography